Nanomedicine & Cancer

Nanomedicine as an innovative and promising alternative technology shows many advantages over conventional cancer therapies and provides new opportunities for early detection, improved treatment, and diagnosis of cancer. Despite the cancer nanomedicines’ capability of delivering chemotherapeutic agents while providing lower systemic toxicity, it is paramount to consider the cancer complexity and dynamics for bridging the translational bench-to-bedside gap. It is important to conduct appropriate investigations for exploiting the tumor microenvironment, This review provides an overview of the current cancer nanomedicines, the major challenges, and the future opportunities in this research area.

 

    Related Conference of Nanomedicine & Cancer

    April 14-15, 2025

    37th Nano Congress for Future Advancements

    Paris, France
    June 16-17, 2025

    42nd Global Nanotechnology Congress

    Amsterdam, Netherlands
    June 24-25, 2025

    28th World Nanotechnology Congress

    Paris, France
    September 22-23, 2025

    35th World Nano Conference

    Dubai, UAE
    October 21-22, 2025

    42nd Global Summit on Nanoscience and Technology

    London, UK

    Nanomedicine & Cancer Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in